Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geohas, C.
Right arrow Articles by McLaughlin, V. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geohas, C.
Right arrow Articles by McLaughlin, V. V.
(Chest. 2003;124:1170-1173.)
© 2003 American College of Chest Physicians

Successful Management of Pregnancy in a Patient With Eisenmenger Syndrome With Epoprostenol*

Chris Geohas, MD and Vallerie V. McLaughlin, MD, FCCP

* From the Division of Cardiology, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL.

Correspondence to: Vallerie V. McLaughlin, MD, FCCP, Rush-Presbyterian-St. Luke’s Medical Center, 1725 W. Harrison St, Suite 020, Chicago, IL 60612; e-mail: vallerie_mclaughlin{at}rush.edu

Pregnancy in the setting of pulmonary hypertension and Eisenmenger physiology is associated with a substantial maternal and fetal risk. Such patients are advised against pregnancy. We report a case of a woman with an Eisenmenger atrial septal defect diagnosed during the last trimester of pregnancy. On presentation, she was critically ill and there was evidence of fetal distress. She was emergently treated with IV epoprostenol, and her status improved. She underwent cesarean section and delivered a male infant with Apgar scores of 8 and 9. Her dyspnea improved, and she was characterized as World Health Organization functional class II on a subsequent clinical visit. Although pregnancy should be discouraged in women with Eisenmenger syndrome, we have demonstrated that IV epoprostenol successfully treated a woman with Eisenmenger syndrome diagnosed in the third trimester.

Key Words: Eisenmenger syndrome • epoprostenol • pregnancy • pulmonary hypertension




This article has been cited by other articles:


Home page
 Obstet GynecolHome page
D. Bendayan, M. Hod, G. Oron, A. Sagie, L. Eidelman, D. Shitrit, and M. R. Kramer
Pregnancy Outcome in Patients With Pulmonary Arterial Hypertension Receiving Prostacyclin Therapy
Obstet. Gynecol., November 1, 2005; 106(5): 1206 - 1210.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.